Suzhou Soho Biomaterials Technology Co., Ltd. is located in Soho Industrial Park, No. 105 Tianshangjiang Road, Wuzhong Economic Development Zone, Suzhou, China. The company provides medical manufacturing enterprises and biotechnology companies with one-stop Tissue Engineering and Regenerative Medicine Contract Development and Manufacturing solutions, including research and development, product testing, animal testing, clinical trials, product registration and contract manufacturing, which it greatly reduces the investment cost and compliance risk before the sale of products of science and innovation enterprises, realises the whole process of product development to manufacturing, and creates new value for health continuously.Soho Biotech has built more than 3,000 square meters of GMP clean workshop and R&D laboratory, equipped with Class 10,000 workshop purification areas, and established biological, chemical and physical testing room, including aseptic testing room, positive control room and microbial limit check room. The company has a team of the leading experts in the field of silk fibroin, the chief scientists of the 13th Five-Year Plan, scientists from Soochow University as the technical consultants. The company owns a complete set of equipment and facilities required for the research and development of silk protein technology, as well as low-temperature and low-humidity production lines to meet the requirements of special products. We have established a perfect R&D and production quality management system, and have realized the transformation of R&D and manufacturing of several biomaterial projects represented by silk fibroin to meet the R&D and manufacturing of various biomaterials and medical devices.

The Tissue Engineering and Regenerative Medicine Biomaterials Laboratory The Healtech CDMO plantfrom undertakes the special project of "National 13th Five Year Key R&D Plan for Biomaterials Research and Development and Organ Repair Replacement", realizing the transformation of scientific and technological achievements in "Engineering preparation technology and product development of low immunogenicity collagen and silk fibroin protein", and further reserving various research and development technologies of new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, pectin, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc.The company provides medical manufacturing enterprises and biotechnology companies with one-stop Tissue Engineering and Regenerative Medicine Contract Development and Manufacturing solutions, including research and development, product testing, animal testing, clinical trials, product registration and contract manufacturing, which it greatly reduces the investment cost and compliance risk before the sale of products of science and innovation enterprises, realises the whole process of product development to manufacturing, and creates new value for health continuously.

Soho Biotech has built more than 3,000 square meters of GMP clean workshop and R&D laboratory, equipped with Class 10,000 workshop purification areas, and established biological, chemical and physical testing room, including aseptic testing room, positive control room and microbial limit check room. The company owns a complete set of equipment and facilities required for the research and development of silk fibroin technology, as well as low-temperature and low-humidity production lines to meet the requirements of special products. Through an experienced and professional production management team, we strengthen the production quality control and process management, focus on compliance as our top priority, and provide high quality and reassuring contract manufacturing services with high standard requirements.We have realized the transformation of R&D and manufacturing of several biomaterial projects represented by silk fibroin to meet the R&D and manufacturing of various biomaterials and medical devices.